Bonus Biogroup (BONS) — Long-term Investment Intensity

Latest as of December 2010: 14.8%

Bonus Biogroup (BONS) has a Long-term Investment Intensity of 14.8% as of December 2010. Long-term investments of ILA900.00K represent 14.8% of total assets of ILA6.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BONS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

14.8%
LT Investments / Total Assets

Long-term Investments

ILA900.00K
ILA

Total Assets

ILA6.07 Million
ILA

Country

Israel
TA

Bonus Biogroup Long-term Investment Intensity (2008–2010)

This chart shows how Bonus Biogroup's Long-term Investment Intensity has evolved across 2 annual periods from 2008 to 2010. As of December 2010, the intensity stands at 14.8%, reflecting long-term investments of ILA900.00K against total assets of ILA6.07 Million ILA. Explore BONS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Bonus Biogroup (2008–2010)

The table below presents the year-by-year Long-term Investment Intensity for Bonus Biogroup from 2008 to 2010, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Bonus Biogroup market cap and net worth.

Year LT Investment Intensity LT Investments (ILA) Total Assets Change (pp)
2010 14.8% ILA900.00K ILA6.07 Million ▲ +13.0 pp
2008 1.8% ILA935.00K ILA50.81 Million
pp = percentage points